A Direct, Plasmin Independent Assay For Plasminogen Activation

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Thrombosis and Haemostasis

• Publication date

  1984-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1055/s-0038-1652445PMID 6233750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The secretion of plasminogen activators by human myeloid leukemic cells in vitro.

  1983cited by this paper
• Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.

  1983cited by this paper
• Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation

  1983cited by this paper
• Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.

  1983cited by this paper
• Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.

  1983cited by this paper
• Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

  1983cited by this paper
• Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

  1982cited by this paper
• Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators

  1982cited by this paper
• Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.

  1982cited by this paper
• A Comparison of Plasminogen Activators Derived from Rat Plasma, Primary Rat Hepatocytes and Isolated Perfused Rat Liver

  1982cited by this paper
• Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.

  1982cited by this paper
• The production of distinct forms of plasminogen activator by mouse embryonic cells.

  1982cited by this paper
• Secretion of Plasminogen Activators by Cultured Bovine Endothelial Cells: Partial Purification, Characterization and Evidence for Multiple Forms

  1981cited by this paper
• HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS *

  1981cited by this paper
• Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells.

  1981cited by this paper
• Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

  1981cited by this paper
• An Inhibitor Of Plasminogen Activator In Rabbit Endothelial Cells

  1981cited by this paper
• Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?

  1981cited by this paper
• Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells.

  1980cited by this paper
• Secretion of a progesterone-induced inhibitor of plasminogen activator by the porcine uterus.

  1980cited by this paper
• On the Regulation and Control of Fibrinolysis

  1980cited by this paper
• Molecular species of plasminogen activators secreted by normal and neoplastic human cells.

  1980cited by this paper
• Natural inhibitors of fibrinolysis.

  1979cited by this paper
• Comparative studies of the fibrinolytic activity of cultured vascular cells.

  1979cited by this paper
• Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue.

  1979cited by this paper
• Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.

  1979cited by this paper
• Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators.

  1979cited by this paper
• Purification and partial characterization of plasminogen activator from human uterine tissue.

  1979cited by this paper
• Isolation of plasminogen activator from human plasma by chromatography on lysine-sepharose.

  1978cited by this paper
• ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS

  1978cited by this paper
• The effect of alpha-,omega-amino acids on human plasminogen structure and activation.

  1978cited by this paper
• Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins.

  1977cited by this paper
• Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.

  1977cited by this paper
• Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Protein iodination with solid state lactoperoxidase.

  1974cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• Differentiation between Plasminogen Activators by Means of Epsilon- Aminocaproic Acid

  1972cited by this paper
• Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin 1

  1971cited by this paper
• Inhibitors of fibrinolysis in human tissues in culture.

  1971cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The specific mechanism of activation of human plasminogen to plasmin.

  1967cited by this paper
• The preparation of human fibrinogen free of plasminogen.

  1962cited by this paper

• Enhanced cell‐associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells

  2010cites this paper
• Acyl-Enzyme Complexes between Tissue-type Plasminogen Activator and Neuroserpin are Short-lived in Vitro*

  2002cites this paper
• Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.

  2001cites this paper
• Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: kinetic analysis.

  2001cites this paper
• Polyphenolics Increase t‐PA and u‐PA Gene Transcription in Cultured Human Endothelial Cells

  2001cites this paper
• Hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene transcription through cis-repressive region(s) in the tissue plasminogen activator promoter in cultured human endothelial cells.

  2000cites this paper
• Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells.

  2000cites this paper
• Two Distinct Urokinase-Serpin Interactions Regulate the Initiation of Cell Surface-associated Plasminogen Activation*

  1999cites this paper
• Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells.

  1998cites this paper
• Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.

  1997cites this paper
• Ethanol increases surface-localized fibrinolytic activity in cultured endothelial cells.

  1997cites this paper
• Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.

  1996cites this paper
• Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.

  1995cites this paper
• Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1 (*)

  1995cites this paper
• Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.

  1994cites this paper
• Cellular Models for Angiogenesis Research

  1994cites this paper
• Biochemical and biological aspects of the plasminogen activation system.

  1990cites this paper
• Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.

  1988cites this paper
• Plasminogen activators and their inhibitors.

  1988cites this paper
• [26] Plasminogen activators and their inhibitors

  1988cites this paper
• Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide.

  1988cites this paper
• Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation.

  1987cites this paper
• Functional assay of plasminogen activator by hydrolysis of 14C-globin.

  1986cites this paper
• An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.

  1986cites this paper
• The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.

  1986cites this paper
• Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.

  1986cites this paper
• The initiation of fibrinolysis in α2-plasmin inhibitor deficient plasma. Role of fibrin

  1986cites this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cites this paper
• Fibrinolysis inhibition in acute respiratory distress syndrome.

  1985cites this paper
• Vascular Smooth Muscle Cells Inhibit the Plasminogen Activators Secreted by Endothelial Cells

  1985cites this paper
• Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

  1984cites this paper